The latest closing stock price for Rigel Pharmaceuticals as of May 29, 2020 is 1.96. The all-time high the last 52 weeks is 2.04. Compare RIGL With Other Stocks Policy | Contact Us Fundamental data from Zacks Investment Research, Inc. The system tracks the Zacks Consensus Estimate -- the consensus measure of Rigel Pharmaceuticals, Inc. RIGL announced that the European Medicines MO Stock News and Research Articles - Altria Group : latest news, headlines and Rigel Pharmaceuticals Inc. (RIGL) have declined to their three-year lows Tobacco Industry Outlook Smoking Hot on Pricing & RRP Focus - www.zacks. com. May 5, 2020 Earnings results for Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) According to Zacks Investment Research, based on 4 analysts' There are currently 4 buy ratings for the stock, resulting in a consensus rating of “Buy.”.
Feb 27, 2020 Rigel (RIGL) delivered earnings and revenue surprises of 9.09% and -2.38%, Do the numbers hold clues to what lies ahead for the stock?
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was a big mover last session, as the company saw its shares rise more than 12% on the day.The move came on solid volume too with far more shares changing Rigel Pharmaceuticals, Inc. (RIGL) Stock Price, Quote ... Find the latest Rigel Pharmaceuticals, Inc. (RIGL) stock quote, history, news and other vital information to help you with your stock trading and investing. RIGL News: Earnings, Analyst Moves, and More
RIGL: Rigel Pharmaceuticals Inc - Earnings Announcements. Stay up to date with lastest Earnings Announcements for Rigel Pharmaceuticals Inc from Zacks
This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% CRMD - CorMedix Inc Stock quote - CNNMoney.com Find real-time CRMD - CorMedix Inc stock quotes, company profile, news and forecasts from CNN Business. Rigel Pharmaceuticals, Inc. - TheStreet - Stock Market
Oct 29, 2019
Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow ... Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release the stock currently carries a Zacks Rank of #3. (RIGL): Free Stock Analysis Report
Zacks Equity Research Zacks May 5, 2020 Rigel Pharmaceuticals (RIGL) came out with quarterly earnings of $0.13 per share, in line with the Zacks Consensus Estimate. This compares to loss of $0.11
RIGL: Rigel Pharmaceuticals, Inc. - Interactive Chart